| Literature DB >> 35168944 |
Sara K Tedeschi1,2, Jacklyn Stratton3, Jack Elias Ellrodt3, Mary Grace Whelan3, Keigo Hayashi3, Kazuki Yoshida3,2, Lin Chen3, Ifeoluwakiisi Adejoorin3, Kathryne Elizabeth Marks3,2, A Helena Jonsson3, Deepak A Rao3,2, Daniel H Solomon3,2.
Abstract
Entities:
Keywords: COVID-19; T-lymphocyte subsets; antirheumatic agents; arthritis; rheumatoid; vaccination
Mesh：
Substances：
Year: 2022 PMID： 35168944 DOI： 10.1136/annrheumdis-2022-222232
Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 27.973